Blockbuster weight loss drugs like Ozempic deliver big re...
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbo...
What’s Happening
Let’s talk about Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity.
But while the results are wild, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common. (yes, really)
Why This Matters
The scientific community tends to find developments like this significant.
Scientists and researchers are watching this development closely.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
What’s your take on this whole situation?
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
